Professor William Rosenberg
Founder, Chief Scientific Officer and Chief Executive Officer
William Rosenberg was educated at the University of Cambridge and Guy’s Hospital, London, qualifying in medicine in 1983. His early medical training was at the MRC-CRC in Northwick Park, London, before moving to Oxford as a clinical registrar in 1987. In 1988 he entered John Bell’s laboratory in The Institute of Molecular Medicine as a Wellcome Trust Clinical Research Training Fellow.
After completing his DPhil, he returned to clinical work, as Clinical Tutor in Medicine in the University of Oxford, a post he held for five years. In this role William completed his clinical training in gastroenterology, hepatology and general medicine, led an MRC funded research group involved in molecular and immunological science, and gained extensive experience in clinical research and medical education.
In 1997, William moved to Southampton with the remit of developing a service for hepatitis C. Over a decade, his group has grown to span epidemiology, clinical research, and basic science. Founded on IP emerging from this basic science research, he began iQur Ltd, the first spin-out company within the School of Medicine at the University of Southampton.
He was Professor of Hepatology in the University of Southampton, and chaired the School of Medicine Liver Group. William became Director of the Wellcome Trust Clinical Research Facility in 2003, and took up Directorship of the Southampton University NHS Trust R&D office in 2005. In 2006 he became Associate Director for Experimental Medicine in the UK Clinical Research Network (UKCRN).
In 2007 Profesor Rosenberg moved to University College London. William Rosenberg currently holds the Peter Scheuer Chair of Liver Diseases, based in the Institute for Liver and Digestive Health in the Division of Medicine, University College London. He is also Clinical Lead for Viral Hepatitis and Consultant Hepatologist at the Royal Free London NHS Foundation Trust.
He is the NIHR national specialty lead for hepatology and Scientific Advisor to the Office for Clinical Research Infrastructure in which capacity he helps co-ordinate translational research and the development of links between the NHS, industry and academia.
His main research interests are in the immunology of viral hepatitis and biomarkers of chronic liver disease.
Professor Rosenberg founded iQur in 2003 and has served as Chief Scientific Officer since then. He was appointed CEO of iQur in February 2007.